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It has been over 10 years since robots have appeared in the
pharmaceutical analysis laboratory. In the early days, it was
common for one selected individual to be responsible for the
programming, usage and maintenance of the robots(s). However,
the increasing use of robotics hasprompted theformation of robotics
’laboratories’ and/or ’groups’. This is especially true when
multiple robotic systems and applications are involved.
Over the past severalyears at ISLAR, many champions of robotics
have given presentations on the setup and usage of robotics within
their organizations. These managers have described both the
’centralized’ and’decentralized’ approaches to the implementation
of robotics. In the centralized system, a single group is charged
with all aspects of the robotic project, including justification,
purchase, validation, use and maintenance. Under such an
arrangement, samples are usually given to the robotics group for
analysis. In contrast, a totally decentralized approach to robotics
would have units interspersed throughout the organization, with
each individual group responsible for their respective unit(s), in
much the same way as liquid chromatographs are considered.
At Hoffmann-La Roche, aspects of both the centralized and
decentralized approaches to robotics are used which make our
combined system the ’best of both worlds’. This paper describes
the Rochephilosophy towards robotics and highlights the advantages
to the system used.
Introduction
The use of automation in the pharmaceutical analysis
laboratory is reaching a level of maturity. The regular
attendees at ISLAR have heard many and varied stories
on the implementation of robotics within analytical
laboratories: presentations have addressed equipment
justification, time savings and impact on analytical
personnel. In the session on ’managing laboratory
automation’ laboratory managers learnt the proper
strategy for such key aspects ofautomation as the selection
of personnel and use of the systems can be the difference
between success and failure of the automation project.
Part of the challenge is the high visibility of the laboratory
robot. Although one can argue that cost is an issue, many
other laboratory instruments, most notably nuclear
magnetic resonance and mass spectrometers, cost much
more than even a fully configured PyRobotics system, yet
it is highly unlikely that the upper level management that
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approved the requisition for that purchase will ever
question its utility or time saving potential. However, as
most of us know, the person who justifies and convinces
management within his or her organization to purchase
a robotics system can be sure to receive frequent reminders
from their superiors that this purchase promised to
improve sample throughput or reduce sample backlog.
For this reason, the proper system for insuring that the
robot is not only used, but receives the attention it needs
to show the greatest return on investment, must be
implemented. The system for operating a robot or, in the
case of several robots, a robotics ’group’ or ’laboratory’
provides the interface between upper level management
and the real work being performed by the robot. It is
critically important that the person or persons in this
group be ofhigh calibre and realize the important service
to the reputation of the laboratory that they fulfill.
In my several years of involvement with laboratory
automation, I have seen many colleagues actually fail, or
at the very least succeed only to the point of that they
became disenchanted with robotics. In most cases this was
due to extreme caution practiced by those individuals who
convinced their management of their companies to take
the plunge and purchase their first robotic system. As
most scientists are inherently cautious (a drawback from
all the years of being taught to approach problems in a
logical fashion), they took it on themselves to justify the
purchase and convince management of its validity. When
the system arrived, they felt that it was their ’baby’ and
took it upon themselves to singlehandedly set up, program
and utilize the new robot. The problem arises as an
individual such as this normally has other obligations with
respect to their job. For example, even a Ph.D. chemist
in a non-supervisory capacity is expected to attend
meetings and make presentations about the projects to
which they are currently assigned. Without the ability to
devote full time to the robot, projects usually linger, or
reach the ’back burner’ status. In many instances, the
robot becomes an unused relic kept in some back room.
The past history of robotic implementation in analytical
development laboratories has not been all grim. There
have been many great success stories of individuals who
managed not only to implement a single robot, but have
also shown the ability to grow and expand the usage of
automation in the analytical laboratory. The automation
’specialist’ was the person who most often contributed to
the successful transfer of a manual analytical method to
a robotic system. The automation specialist was that
unique individual who not only had the correct blend of
analytical background, computer literacy and ability to
work with instrumentation, but also had the time to
contribute to taking the project to fruition. Indeed, as
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specialist would be unique for a time, but would
eventually become commonplace. At ISLAR 1984, Frank
Zenie said that: ’Automation specialists are emerging as
a new function in the laboratory. This evolution is similar
to that which created the need for chemical engineers
and, more recently, computer specialists. In the future,
as this technology becomes widely used, these specialists
will disperse back into the operating organization’ [1].
This was proven to be true. In a plenary address at ISLAR
1992, Dr Eugene McGonigle of Schering-Plough pointed
out that the evolution of robotics within his organization
has resulted in automated methods being developed by
’all laboratory staff, not a specially trained few’ [2]. This
implies that the natural progression of a new technology,
such as robotics, into an existing analytical organization
which is keyed in to new technology has the new
technique first utilized by a select few individuals,
followed by everyone in the laboratory. Indeed, there are
many who liken the development of robotics to that of
high performance liquid chromatography (HPLC) in the
late 1960s and early 1970s.
When faced with the task of successfully implementing
robotics within the Pharmaceutical Analysis Laboratories
of Hoffmann-La Roche, we sought to use the evidence of
the past to guide us in forming the proper strategy for the
utilization of this technique.
Robotics at Hoffman-La Roche
The Pharmaceutical Analysis Research and Development
(PARD) section of the Pharmaceutical Quality Control
and Quality Assurance Department serves as the total
analytical support function for the development of drug
substance synthetic processes and the corresponding
dosage forms. The primary responsibilities of PARD are:
(1) Develop/validate analytical methods and test pro-
cedures for drug substances, dosage forms (formula-
tions), packaging components, intermediates, blends,
granulations etc.
(2) Provide release and stability testing (support) for
clinical materials. Serve as the ’quality unit’ for
research compounds and products.
(3) Perform analytical investigations in conjunction
with other departments.
(4) Prepare regulatory documentation (INDs/NDAs/
amendments/supplements).
(5) Perform analytical research as it relates to new
analytical technology/techniques/methods for phar-
maceutical analysis. Publish/present results of experi-
ments/studies.
(6) Participate in regulatory inspections and answer
FDA questions.
(7) Support various development departments within
the R&D framework of the company.
In the Roche project team approach to development,
analytical R&D is considered a true partner in drug
development. For this reason, individuals from PARD
serve on international project teams which are charged
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with moving a project along its development pathway.
The challenge within the analytical R&D setting is to
implement systems and techniques to help meet the
aggressive deadlines imposed by project management.
Laboratory automation is one way in which the operation
has been streamlined. While there are many reasons to
automate the major reasons for moving in this direction
are:
(a) Superior productivity.
(b) Ability to perform more complex test procedures.
(c) ’Just in time’ analyses.
(d) Improved precision of analysis.
(e) Reduce cost of analysis.
(f) Efficient transfer to multiple sites.
(g) Effective use of space.
(h) Documentation.
(i) Safeguard personnel from highly potent and some-
what unknown substances.
(j) Ability to analyse highly unstable and photolabile
materials.
In trying to achieve these results, we tried to ascertain
which manner of laboratory or group would best serve
our needs. The choices were limited to: centralization of
the robotics function; total decentralization; some com-
bination of the first two.
In a centralized laboratory, all robotic systems are
under the control of a single person or group. A common
example of a centralized function in most analytical
laboratory setups is nuclear magnetic resonance spectros-
copy (NMR). Most analysts working in the development
of new products or processes do not run their own
NMR spectra, but rather submit samples to the NMR
laboratory, who provides the services of running the
sample, providing a spectrum and corresponding inter-
pretation. The advantages of a centralized laboratory are
that all equipment is operated in the same fashion. In
addition, it is validated and maintained at the same level
ofcompliance. The major disadvantage of the application
of this approach to managing a robotics laboratory is that
the continuing success of the operation depend on a small
group of individuals who hold the ’keys to the kingdom’.
There have been several situations where the lead person
(automation specialist) was lured away by a competing
organization. This can be disastrous to an automation
effort as it is difficult to keep such a program underway
without a key player to drive the project.
Under a decentralized structure, all personnel working in
a laboratory have access to or perform a specific technique
on a routine basis. The most common example of a
decentralized technique is high performance liquid
chromatography (HPLC). While this overcomes the
disadvantage ofhaving only a select individual possess all
the knowledge needed to pursue robotics, the drawback
is that all users are free to exercise their own judgement
with respect to implementing automated methods. In
addition, one true source of training and guidance is not
available under a decentralized system.S. Scypinski et al. ISLAR 1994
The hybrid approach at Hoffmann-La Roche combines
the best characteristics of both the centralized and
decentralized systems of robotics. The specific positive
aspects of the combined approach are:
(1) Equipment is maintained and validated in a uniform
manner by a central group. Standard Operating
Procedures (SOPs) are written and enforced by this
group.
(2) Robotic systems are accessible and usable by other
members ofthe laboratory for both development work
as well as routine analysis.
(3) Automation projects have a high probability of
success under this system, as a mix ofrobotics expertise
and specific chemistry background contribute to and
reinforce the project.
(4) The people working on the project benefit from the
sharing of ideas and experience.
(5) The individuals and/or groups can obtain ownership
of a project without actually having to directly
supervise individuals.
Under the combination approach, assigned individuals
tiom both the robotics group and the specific analytical
area work together to develop and validate automated
methods for developmental products. It is also the
combined efforts of both individuals which produce the
required documentation, including the pertinent portions
of the regulatory submission, necessary to show that the
automated method is indeed successful.
The robotics laboratory at Hoffman-La Roche is also
charged with the development and validation of methods
for marketed products as well. In this age of ’less with
more’, we identified several high-volume.marketed
products which would benefit from their application of
robotics, either because the method is simple and the sheer
volume ofsamples makes the use ofautomation attractive,
or the analysis is complex and requires special con-
siderations, such as the stipulation that the analysis must
be carried out in the dark due to the photolability of the
sample. There are several products which fit either of the
two catagories and these manual methods are being
converted to automated procedures. It is hoped to create
’turnkey analysers’, which may be easily used by all
laboratory personnel with some experience in basic
analytical chemistry. It should be pointed out here that
another ploy to ensuring the success of robotics within an
organization is to make it accessible, i.e. usable, by as
large a population as possible.
A key to the success of the implementation of robotics in
an analytical development laboratory is the ’building in’
of the capability of converting to robotics even in the
manual methods. For example, when working up a sample
preparation procedure for a tablet assay method, it is
important to add several intact tablets to a specified
volume of diluent followed by some sort of agitation. This
mixture is then filtered and diluted prior to analysis by
HPLC. This procedure is easily transferred to the robot
without the need to perform lengthy equivalency studies
between incompatible procedures, such as the use of
grinding several tablets together and adding a single tablet
weight to the diluent prior to HPLC injection. One of the
charges of the robotics personnel is to impress upon the
method development chemists the need to consider the
use of automation, even though it may be several years
before the sample volume makes the use of robotics
attractive.
The key to the success of such a program as has been
described here is the personnel. The proper candidate for
the robotics laboratory has the following qualifications
and background:
(1) A solid foundation in analytical chemistry, including
method development and validation. The individual
should preferably have come from the development
laboratory.
(2) Computer literate and willing to learn about new
areas.
(3) Not be adverse to getting dirty hands and working
with mechanical things.
(4) Have good interpersonal skills.
(5) Not be connected with other duties, especially those
of an administrative nature.
(6) Finally, they must be very patient.
Conclusions
The centralized/decentralized concept of robotics has
been in place at Hoffmann-La Roche for approximately
three years. It is working well within the organization
and has been applied to the functionalization of other
areas, such as gas chromatography.
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